// company-profile

Evolus, Inc.

EOLS
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings80Insiders13
// api This Evolus, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

No insider transactions in the last 30 days.

No insider activity recorded for EOLS in the last 90 days.

Institutional Ownership

Top 13F-HR holders of Evolus, Inc. as of 2026-03-31

↓ decreasing
Total reported AUM
$186.8M
QoQ change
-36.7%
Reporting period
2026-03-31
#1
Nantahala Capital Management, LLC
CIK 1472322
$26.2M
6.4M shares
#2
BRAIDWELL LP
CIK 1920938
$12.8M
3.1M shares
#3
Frazier Life Sciences Management, L.P.
CIK 1892134
$10.8M
2.6M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Mar 20, 2026Avelar RuiEOLS
Sale10b5
3,119$4.75$15K
Mar 20, 2026MOATAZEDI DAVIDEOLS
Sale10b5
13,669$4.75$65K
Mar 17, 2026Avelar RuiEOLS
Sale10b5
29,996$4.89$147K
Mar 17, 2026MOATAZEDI DAVIDEOLS
Sale10b5
116,720$4.89$571K
Mar 16, 2026Avelar RuiEOLS
Option Exercise
8,804$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.